Pancreatic Cancer, Research and Clinical Trials

Meet the investigator: Daniel D. Billadeau, Ph.D.

By Nicole Ferrara • December 11, 2019
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer pancreatic cancer Pancreatic Cancer research Research and Clinical Trials SPORE
Subscribe
Request an Appointment
Find a Clinical Trial
Researchers make unexpected discovery in how pancreatic cancer spreads

They identified a cell-signaling protein that drives pancreatic cancer cell growth that could be a potential therapeutic target.

Mayo Clinic’s AI innovation inspires hope in early detection of pancreatic cancer

Researchers built a highly accurate artificial intelligence model for fully automated cancer detection, including small and otherwise difficult-to-detect tumors.

Looking back on pancreatic cancer, 5 years later

Rita Krueger shares the lessons she has learned from her experience with pancreatic cancer diagnosis, treatment and survivorship.